When is photodynamic therapy recommended for basal cell carcinoma?

A photosensitising medicine is applied to the skin and then activated with a specific light. The process targets abnormal cells near the surface. It is generally considered when the carcinoma is superficial rather than a deeper, thick, recurrent, or otherwise higher-risk tumour. The location, size, edges, previous treatment, immune health, and appearance of the lesion all influence the choice.

A biopsy or clinical examination may be needed before treatment. Photodynamic therapy can leave treated skin red, tender, crusted, or sensitive to light for a period after the session, so the clinician will explain wound care and light precautions.

Arrange a dermatology assessment rather than choosing treatment from the lesion’s appearance alone. Bring details of previous biopsies, creams, freezing, surgery, or other treatment. Tell the clinician about medicines that increase light sensitivity, immune conditions, easy bleeding, and any difficulty protecting the treated area from bright light.

Ask whether the lesion is superficial and whether photodynamic therapy is appropriate for its exact site. Discuss alternatives such as excision or another skin-directed treatment, how the area will be protected afterwards, and how follow-up will check that the carcinoma has cleared.

Seek prompt dermatology review for a sore that does not heal, a spot that repeatedly bleeds or crusts, a shiny or pearly growth, or a lesion that is enlarging or changing. After treatment, contact the clinic promptly for spreading redness, worsening pain, pus, fever, or an eye-area reaction.

Is this basal cell carcinoma superficial, and has it been confirmed if a biopsy is needed? Why would photodynamic therapy fit this lesion better or less well than surgery or another option? What light sensitivity precautions and follow-up plan will I need?